跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Solu-Medrol 500mg powder for injection vial with diluent vial - TGA Drug Approval Details
Approvals
/
TGA
/
Solu-Medrol 500mg powder for injection vial with diluent vial
Approved
STANDARD
Solu-Medrol 500mg powder for injection vial with diluent vial
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
472f531d5fbdf25a
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
472f531d5fbdf25a
Product Name
Solu-Medrol 500mg powder for injection vial with diluent vial
Artg Id
12344
Artg Name
SOLU-MEDROL methylprednisolone (as sodium succinate) 500mg powder for injection vial with diluent vial
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1991-08-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-05517-3
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-05516-3
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
472f531d5fbdf25a
Type
Standard
Back to TGA Approvals